Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cel-sci (CVM)
:CVM
Holding CVM?
Track your performance easily
CVM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.36 - $3.08
Previous Close$0.36
Volume1.47M
Average Volume (3M)1.53M
Market Cap
$29.57M
Enterprise Value$74.50M
Total Cash (Recent Filing)$2.37M
Total Debt (Recent Filing)$13.21M
Price to Earnings (P/E)―
Beta1.76
Next Earnings
Feb 13, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.50
Shares Outstanding74,107,040
10 Day Avg. Volume1,070,675
30 Day Avg. Volume1,531,486
Standard Deviation0.27
R-Squared0.02
Alpha-0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.50
P/FCF Ratio0.00
Enterprise Value/Market Cap2.52
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-3.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Cel-Sci News
Ownership Overview
2.19% Insiders
4.07% Mutual Funds
<0.01% Other Institutional Investors
90.42% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CVM FAQ
What was Cel-sci’s price range in the past 12 months?
Cel-sci lowest stock price was $0.36 and its highest was $3.08 in the past 12 months.
What is Cel-sci’s market cap?
Cel-sci’s market cap is $29.57M.
When is Cel-sci’s upcoming earnings report date?
Cel-sci’s upcoming earnings report date is Feb 13, 2025 which is in 22 days.
How were Cel-sci’s earnings last quarter?
Cel-sci released its earnings results on Dec 18, 2024. The company reported -$0.096 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.096.
Is Cel-sci overvalued?
According to Wall Street analysts Cel-sci’s price is currently Overvalued.
Does Cel-sci pay dividends?
Cel-sci does not currently pay dividends.
What is Cel-sci’s EPS estimate?
Cel-sci’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Cel-sci have?
Cel-sci has 74,107,040 shares outstanding.
What happened to Cel-sci’s price movement after its last earnings report?
Cel-sci reported an EPS of -$0.096 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -18.421%.
Which hedge fund is a major shareholder of Cel-sci?
Currently, no hedge funds are holding shares in CVM
---
Cel-Sci Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-83.45%
12-Months-Change
Fundamentals
Return on Equity
-206.43%
Trailing 12-Months
Asset Growth
-11.58%
Trailing 12-Months
Company Description
Cel-sci
CEL-SCI Corp. is a biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients; and CEL-2000 and CEL-4000 which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.
---
Technical Analysis
Inovio Pharmaceuticals
―
Advaxis
―
Northwest Biotherapeutics
―
Cyclacel Pharmaceuticals
―
ImmunoCellular Therapeutics
―
---